Semaglutide Winning Streak Continues in CKD With FLOW
Topline results from this kidney outcomes trial showed the GLP-1 injectable significantly cut kidney and CVD events vs placebo.
Topline results from this kidney outcomes trial showed the GLP-1 injectable significantly cut kidney and CVD events vs placebo.
Preventive Cardiologist writing on how to prevent heart disease and live longer. Click to read Dr Paddy Barrett, a Substack publication.
Adoption approached 60% as recently as 2022
From protocol development to timely recruitment and retention to regulatory approval, it is crucial that trial subjects feel involved, retain their autonomy…
Although orthostatic hypotension (OH) has long been recognized as a manifestation of autonomic dysfunction, a growing body of literature has identified OH as a common…
As part of infrastructure enhancements to ACC-related systems and platforms, the ability to log-in to JACC.org using ACC usernames and passwords will be unavailable from…
Jagmeet Singh joins Harriette Van Spall to discuss artificial intelligence in the realm of heart failure.
AcuteCVDays, brought to you by the Association for Acute Cardiovascular Care (ACVC), facilitates learning and discussing potential differences between North America and Europe in the…
The approval marks the return of the dissolving-scaffold concept, which so far has failed to find success in the coronaries.
Show Pediheart: Pediatric Cardiology Today, Ep Pediheart Podcast #295: Right Atrial Thrombus Post Gore Cardioform ASD Closure – Reason For Concern? – May 2, 2024